Clinical Trial Details Page

LUNG-MAP

Objective

Master Protocol to Evaluate Biomarker-Drive Therapies and Immunotherapies in Previously Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study) - associated with biomarker driven sub-studies. For more information contact Nancy Burns at 919-784-7209.

IRB Protocol Number
NCT03851445

Clinical Trial Categories

  • Lung Cancer
Contact
Nancy Burns at 919-784-7209
or Nancy.Burns2@unchealth.unc.edu
How to Participate

View eligibility criteria and additional study information.

Related Locations